INTERPACE BIOSCIENCES, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
INTERPACE BIOSCIENCES, INC. (IDXG) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $419.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $419.00K.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.03M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.02M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $2.06M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits as first filed |
|---|---|---|
| 2025-12-31 | $419.00K 10-K · filed 2026-03-30 | |
| 2024-12-31 | $2.03M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $2.02M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $2.06M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $1.84M 10-K · filed 2023-03-27 | |
| 2020-12-31 | $1.49M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $1.40M 10-K · filed 2021-04-01 | |
| 2018-12-31 | $1.10M 10-K/A · filed 2021-01-19 | |
| 2017-12-31 | $693.00K 10-K · filed 2019-03-21 | |
| 2016-12-31 | $1.29M 10-K · filed 2018-03-23 | |
| 2015-12-31 | $2.18M 10-K · filed 2017-03-31 | |
| 2014-12-31 | $3.64M 10-K · filed 2016-03-30 | |
| 2013-12-31 | $4.01M 10-K · filed 2015-03-05 | -$4.01M 10-K · filed 2014-03-06 |
| 2012-12-31 | -$3.38M 10-K · filed 2014-03-06 | |
| 2011-12-31 | -$3.56M 10-K · filed 2013-03-15 |